Phase II/III study comparing Trabectedin (T) versus T plus tTF-NGR to entrap T inside the tumor in patients with metastatic and/or refractory soft tissue sarcoma (STS; 2nd line)

Beteiligte Wissenschaftler:
Akad. Rat Dr. Dipl.-Stat. J. Gerß

Studienleitung:
Univ.-Prof. Dr. med. C. Schliemann